C3 and polycystic ovary syndrome: A recent study has shown a strong association of serum complement C3 with serum insulin and insulin resistance in subjects with PCOS, suggesting that this inflammatory marker might predict future diabetes and CVD complication risk in subjects with PCOS [56].